In vivo TLD dosimetry possible in mammography.

2004 AUG 5 - (NewsRx.com & NewsRx.net) -- Scientists in Australia say that in vivo adjustment in radiation dose for women undergoing mammography is possible using thermoluminescent dosimeters.

"While phantoms are used for quality control assessment of the mammography unit, in vivo dose measurements are necessary to account for the variation in size and composition of the female breast. The use of thermoluminescent dosimeters (TLDs) in mammography has been limited due to TLD visibility. The aim of this current investigation was to access the suitability of a paper-thin LiF:Mg,Cu,P TLD (GR-200F) for in vivo dosimetric mammography measurements," said H.M. Warren-Forward and colleagues, University of Newcastle, School of Health Science.

"The visibility of GR-200F has been directly compared with LiF:Mg,Cu,P TLDs (GR-200A) using a number of commercially available phantoms. The phantoms of thickness 2-5 cm were imaged over the range of tube potentials (24-28 kVp) used clinically. Both types of TLD were placed on the surface of the phantoms allowing assessment of visibility, entrance surface dose (ESD) and field homogeneity. In vivo assessment of ESD and visibility was also carried out on a volunteer undergoing a routine mammography examination," the researchers said.